US Patent 10059993 Oligonucleotides for controlling amplification of nucleic acids
Patent 10059993 was granted and assigned to Roche Molecular Systems on August, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+149 characters)
Article
Patent abstract
Methods and oligonucleotides are provided for detecting an internal control nucleic acid for qualitative and/or quantitative purposes.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Ellen H. Fiss0
Nicolas Newton0
Edits on 3 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 15 Feb, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100599930
Date of Patent
August 28, 2018
0Patent Application Number
148379310
Date Filed
August 27, 2015
0Patent Primary Examiner
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10059993 Oligonucleotides for controlling amplification of nucleic acids
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10059993
Date of patent
August 28, 2018
Patent application number
14837931
Date Filed
August 27, 2015
Patent primary examiner
Find more entities like US Patent 10059993 Oligonucleotides for controlling amplification of nucleic acids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
